Emerade (epinephrine bitartrate)

pCPA File Number: 21161

Negotiation Status:

Concluded with an LOI

Indication(s):

For the emergency treatment of severe acute allergic reactions (anaphylaxis).

Sponsor/Manufacturer:

Bausch Health, Canada Inc.

CDA-AMC Project Number:

Not Applicable

pCPA Engagement Letter Issued:

2019-08-30

Negotiation Process Concluded:

2020-02-04